Biochemical differentiation of the porphyrias

Clinical Biochemistry

Volumn 32, Issue 8, 1999, Pages 609-619

  Hindmarsh, J Thomas ^a,b   Oliveras, Linda ^a   Greenway, Donald C ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Abdominal pain; Blood; Erythema; Erythrocytes; Feces; Neuropathy; Photodermatitis; Plasma; Porphyria; Porphyrins; Renal failure; Urine; Urticaria

Indexed keywords

AMINOLEVULINIC ACID; PORPHOBILINOGEN; PORPHOBILINOGEN DEAMINASE; PORPHYRIN; PORPHYRIN DERIVATIVE; PROTOPORPHYRIN;

ACUTE INTERMITTENT PORPHYRIA; ARTICLE; CLINICAL FEATURE; COPROPORPHYRIA; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVITY; ERYTHROCYTE LEVEL; ERYTHROPOIETIC PROTOPORPHYRIA; FECES LEVEL; HUMAN; PORPHYRIA; PORPHYRIA CUTANEA TARDA; PORPHYRIA VARIEGATA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FECES; HUMANS; PORPHYRIA CUTANEA TARDA; PORPHYRIA, ACUTE INTERMITTENT; PORPHYRIA, HEPATOERYTHROPOIETIC; PORPHYRIAS; PORPHYRIAS, HEPATIC; PORPHYRINS;

EID: 0033451127     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(99)00067-3     Document Type: Article

References (46)

1. Elder G.H., Smith S.G., Smyth S.J. Laboratory investigation of the porphyrias. Ann Clin Biochem. 27:1990;395-412.
2. Hindmarsh J.T. Enzyme assays and the porphyrias which tissues and when indicated . Clin Dermatol. 16:1998;245-250.
3. Elder G.H. Genetic defects in the porphyrias. Clin Dermatol. 16:1998;225-233.
4. Hindmarsh J.T., Oliveras L., Greenway D.C. Plasma porphyrins in the porphyrias. Clin Chem. 45:1999;1070-1076.
5. Johnson P.M., Perkins S.L., Kennedy S.W. A high speed liquid-chromatographic method for measuring urine porphyrins. Clin Chem. 34:1988;103-105.
6. Pudek M., Schreiber W.E., Jamani A. Quantitative fluorometric screening test for fecal porphyrins. Clin Chem. 37:1991;826-831.
7. Piomelli S. Free erythrocyte porphyrins in the detection of undue absorption of Pb and of Fe deficiency. Clin Chem. 23:1977;264-269.
8. Piepkorn M.W., Hamernyik P., Labbé R.F. Modified erythrocyte uroporphyrinogen I synthase assay, and its clinical interpretation. Clin Chem. 24:1978;1751-1754.
9. Mauzerall D., Granick S. The occurrence and determination of delta-aminolevulinic acid and porphobilinogen in urine. J Biol Chem. 219:1956;435-446.
10. Deacon A.L. Performance of screening tests for porphyrins. Ann Clin Biochem. 25:1988;392-397.
11. Zuijderhoudt F.M.J., Dorresteijn-de Bok J., Te Velde K. Evaluation of a first-line spectrophotometric screening test for increased urine porphyrin excretion. Ann Clin Biochem. 32:1995;186-189.
12. Zuijderhoudt F.M.J., Dorresteijn-de Bok J., Te Velde K. Evaluation of a first-line spectrophotometric screening test for increased fecal porphyrin concentration. Eur J Clin Chem Clin Biochem. 33:1995;285-288.
13. National Committee for Clinical Laboratory Standards. How to define and determine reference intervals in the clinical laboratory: approved guideline. NCCLS document C28-A. Villanova, PA: National Committee for Clinical Laboratory Standards, 1995.
14. Gray C.H., Lim C.K., Nicholson D.C. The differentiation of the porphyrias by means of high pressure liquid chromatography. Clin Chim Acta. 77:1977;167-178.
15. McCarrol N.A. Serious overestimation of endogenous fecal porphyrin concentrations by solvent-extraction techniques, as demonstrated by HPLC. Clin Chem. 34:1988;2390-2391.
16. Schreiber W.E., Raisys V.A., Labbé R.F. Liquid chromatographic profiles of urinary porphyrins. Clin Chem. 29:1983;527-530.
17. Lim C.K., Peters T.J. Urine and fecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias. Clin Chim Acta. 139:1984;55-63.
18. Beukeveld G.J.J., Wolthers B.G., van Saene J.J.M., de Haan T.H.I., de Ruyter-Bultenhuis L.W., van Saene R.H.F. Patterns of porphyrin excretion in feces as determined by liquid chromatography reference values and the effect of flora suppression . Clin Chem. 33:1987;2164-2170.
19. Kalb R.E., Grossman M.E., Poh-Fitzpatrick M.B. Correlation of serum and urinary porphyrin levels on porphyria cutanea tarda. Arch Dermatol. 121:1985;1289-1291.
20. Moore M.R., McColl K.E.L., Rimington C., Goldberg A. Disorders of porphyrin metabolism. 1987;Plenum, New York.
21. Boynton S.B., Roth K.S. Rapid and accurate random urinary porphyrin quantitation. Clin Chim Acta. 226:1994;1-11.
22. Nuttall K.L., Pingree S.S., Ashwood E.R. Reference intervals for 24-hour and random urine porphyrins. Ann Clin Lab Sci. 26:1996;313-322.
23. Logan G.M., Weiner M.K., Ellefson M., Pierach C.A., Bloomer J.R. Bile porphyrin analysis in the evaluation of variegate porphyria. N Engl J Med. 324:1991;1408-1411.
24. Henry RJ. Clinical chemistry, principles and technics. 878. New York: Harper and Row, 1964.
25. Jacob K., Doss M.O. Excretion pattern of fecal coproporphyrin isomers I-IV in human porphyrias. Eur J Clin Chem Clin Biochem. 33:1995;893-901.
26. Badcock N.R., Szep D.A., Zoanetti G.D., Lewis B.D. Fecal coproporphyrin isomer in sporadic and familial porphyria cutanea tarda. Clin Chem. 41:1995;1315-1317.
27. D'Alessandro R., Rocchi E., Cristina E., et al. Safety of valproate in porphyria cutanea tarda. Epilepsia. 29:1988;159-162.
28. Yeung-Laiwah A.A.C., Thompson G.C., Philip M.F., et al. Carbamazepine-induced non- hereditary acute porphyria. Lancet. 1:1983;790-792.
29. Long C., Smyth S.J., Woolf J., et al. Detection of latent variegate porphyria by fluorescence emission spectroscopy of plasma. Br J Dermatol. 129:1993;9-13.
30. With T.K. The clinical chemistry of the porphyrias. Clin Biochem. 1:1968;224-242.
31. Ratnaike S., Blake D. The diagnosis and follow-up of porphyria. Pathology. 27:1995;142-153.
32. Wassif W.S., Deacon A.C., Floderus Y., Thunell S., Peter T.J. Acute intermittent porphyria diagnostic conundrums . Eur J Clin Chem Clin Biochem. 32:1994;915-921.
33. Stein J.A., Tschudy D.P. Acute intermittent porphyria a clinical and biochemical study of 46 patients . Medicine (Baltimore). 49:1970;1-16.
34. Longas M.O., Poh-Fitzpatrick M.B. A tightly bound protein-porphyrin complex isolated from the plasma of a patient with variegate porphyria. Clin Chim Acta. 118:1982;219-228.
35. Andrews J., Erdjument H., Nicholson D.C. Hereditary coproporphyria incidence in a large English family . J Med Genet. 21:1984;341-349.
36. Gebril M., Weinkove C., Ead R., McDonald K., Morton R. Plasma porphyrins in chronic renal failure. Nephron. 55:1990;159-163.
37. Blake D., McManus J., Cronin V., Ratnaike S. Fecal coproporphyrin isomers in hereditary coproporphyria. Clin Chem. 38:1992;96-100.
38. Schoenfeld N., Mamet R., Dotan I., Sztern M., Levo Y., Aderka D. Relationship between uroporphyrin excretion, acute attacks of hereditary coproporphyria and successful treatment with heme arginate. Clin Sci. 88:1995;365-369.
39. Doss M.O., Frank M. Hepatobiliary implications and complications in protoporphyria, a 20-year study. Clin Biochem. 22:1989;223-229.
40. Day R.S., Eales L., Meissner D. Coexistant variegate porphyria and porphyria cutanea tarda. N Engl J Med. 307:1982;36-41.
41. Sieg I., Bhutani L.K., Doss M.O. Dual porphyria of coexisting variegata and cutanea tarda. Eur J Clin Chem Clin Biochem. 33:1995;405-410.
42. Blake D., Poulos V., Rossi R. Diagnosis of porphyria, recommended methods for peripheral laboratories. Clin Biochem Rev. 13:1992;S1-S24.
43. Buttery J.E., Chamberlain B.R., Beng C.G. A sensitive method of screening for urine porphobilinogen. Clin Chem. 35:1989;2311-2312.
44. Schreiber W.E., Jamani A., Pudek M.R. Screening tests for porphobilinogen are insensitive. Clin Biochem. 22:1989;262.
45. Mustajoki P. Normal erythrocyte uroporphyrinogen I synthase in a kindred with acute intermittent porphyria. Ann Intern Med. 95:1981;162-166.
46. De Salamanca R.E., Sepulveda P., Moran M.J., Santos J.L., Fontanellas A., Hernandez A. Clinical utility of fluorometric scanning of plasma porphyrins for the diagnosis and typing of porphyrias. Clin Exp Dermatol. 18:1993;128-130.